Elevated anti-inflammatory cytokines (IL-4 and IL-10) and neurotrophic factors (BDNF, IGF-1) in silymarin-treated mice suggest that silymarin may offer neuroprotective benefits by mitigating obesity-related neuroinflammation. Here, IL10 is linked to obesity due to melanocortin 4 receptor deficiency.